A new study in animals shows that chronic stress during pregnancy prevents brain benefits of motherhood, a finding that researchers suggest could increase understanding of postpartum depression.
Oct 14, 2012
2
0
(Medical Xpress) -- According to a new study published in Neuropsychopharmacology, researchers, led by Gunther Meinlschmidt, PhD, may have found a connection between the brain chemical oxytocin and postpartum depression.
A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds a clinical trial published ...
Apr 10, 2024
0
56
Pregnancy and childbirth can be significant stressors on mental health. Nearly one in eight people who have given birth develop postpartum depression, according to the Centers for Disease Control and Prevention. More than ...
Apr 1, 2024
0
0
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish ...
Mar 15, 2024
0
1
Becoming a parent comes with lots of bills. For new mothers, being able to afford the rent may help stave off postpartum depression.
Mar 7, 2024
0
0
Results from a large clinical trial show that an intervention for anxiety provided to pregnant women living in Pakistan significantly reduced the likelihood of the women developing moderate-to-severe anxiety, depression, ...
Feb 26, 2024
0
2
The changes of motherhood can make women vulnerable to negative body image, but experts at Flinders University are encouraging women to embrace body image interventions to combat this.
Feb 20, 2024
0
0
Researchers from McMaster University have found that cognitive behavioral therapy (CBT) provided to mothers with postpartum depression (PPD) by public health nurses may lead to adaptive changes in brain development for their ...
Jan 29, 2024
0
2
The first pill for postpartum depression approved by the U.S. Food and Drug Administration is now available, but experts worry that minority and low-income women, who are disproportionately affected by the condition, won't ...
Jan 15, 2024
0
0
